drugset / Trial / NCT00592930
Olanzapine in the Treatment of Anorexia Nervosa
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study compared 10 weeks of treatment with olanzapine versus placebo in adolescent females with anorexia nervosa-restricting type who were undergoing acute treatment on an inpatient unit or a day hospital program that specializes in the treatment of eating disorders.
Timeline
- Start
- 2000-06
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 2.5 mg | Oral |
| Subject | Olanzapine | Small molecule | 15 mg | Oral |